TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials
Year: 2020
Type: review
Source: Cancer Gene Therapy
Institutions: University of Kansas, University of Toledo
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3019755975
